Table 1 Baseline characteristics of the study population, n = 13
Characteristic | Value |
|---|---|
Age (years), mean ± SD | 44 ± 8 |
Sex, female, n (%) | 8 (73) |
Weight (kg), mean ± SD | 63.5 ± 7.5 |
Drug frequency n (%) | |
Nevirapine | 13 (100) |
Tenofovir/lamivudine | 10 (77) |
Stavudine/lamivudine | 2 (15) |
Zidovudine/lamivudine | 1 (8) |
Cotrimoxazole | 9 (69) |
Other drugsa | 3 (23) |